NCT03615300

Predicting Long-term Outcomes After Cardiac Arrest by Using Serum NGAL

Predicting Long-term Outcomes After Cardiac Arrest by Using Serum NGAL: A Prospective, Observational Study

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 73 (actual)
• Sponsor: Uijeongbu St. Mary Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study was performed to determine the prognosis of patients after cardiac arrest using serum markers called NGAL. The initial NGAL values of patients with post-cardiac arrest syndrome are checked by blood tests, and the long-term neurological prognosis and survival rate are collected after 6 months.

Detailed description

Serum NGAL is currently being used as a test to determine the likelihood of developing renal failure. However, in a previous study, serum NGAL correlated with neurological prognosis in post cardiac arrest syndrome patients. This prospective study attempts to see the role of serum NGAL as a prognostic factor by including a sufficient number of patients.

Conditions

• Out-of-Hospital Cardiac Arrest

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	serum NGAL	serum NGAL was measured at 0, 24, 48, and 72 hours after recovery of spontaneous circulation.

Timeline

• Start date: 2018-06-28
• Primary completion: 2022-05-01
• Completion: 2022-05-01
• First posted: 2018-08-03
• Last updated: 2024-05-13

Locations

1 site across 1 country: South Korea